MedPath
TGA Approval

NAROPIN 0.5% ropivacaine hydrochloride 50mg/10mL injection ampoule (52402)

52402

NAROPIN 0.5% ropivacaine hydrochloride 50mg/10mL injection ampoule

Aspen Pharmacare Australia Pty Ltd

January 30, 1996

Medicine

Medicine

Active

Registered

Product Information

Product Information

https://medical-cdn.nocode.com/drug_tga/3d5a80635b5afe13140a07ec2ccfdc29.pdf

Active Ingredients

ropivacaine hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.